Return On Assets in % of Janux Therapeutics, Inc. from Q1 2022 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Janux Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2022 to Q3 2025.
  • Janux Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2025 was -9.78 %, a 0.81% increase year-over-year.
  • Janux Therapeutics, Inc. annual Return On Assets for 2024 was -8.8 %, a 44.8% increase from 2023.
  • Janux Therapeutics, Inc. annual Return On Assets for 2023 was -16 %, a 5.51% increase from 2022.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)

Janux Therapeutics, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -9.78 +0.08 +0.81% Jul 1, 2025 Sep 30, 2025
Q2 2025 -11 -2.8 -34.1% Apr 1, 2025 Jun 30, 2025
Q1 2025 -8.89 +3.48 +28.1% Jan 1, 2025 Mar 31, 2025
Q4 2024 -8.8 +7.15 +44.8% Oct 1, 2024 Dec 31, 2024
Q3 2024 -9.86 +7.46 +43.1% Jul 1, 2024 Sep 30, 2024
Q2 2024 -8.2 +10.7 +56.6% Apr 1, 2024 Jun 30, 2024
Q1 2024 -12.4 +5.79 +31.9% Jan 1, 2024 Mar 31, 2024
Q4 2023 -16 +0.93 +5.51% Oct 1, 2023 Dec 31, 2023
Q3 2023 -17.3 -1.32 -8.25% Jul 1, 2023 Sep 30, 2023
Q2 2023 -18.9 -4.6 -32.2% Apr 1, 2023 Jun 30, 2023
Q1 2023 -18.2 -6.76 -59.3% Jan 1, 2023 Mar 31, 2023
Q4 2022 -16.9 Oct 1, 2022 Dec 31, 2022
Q3 2022 -16 Jul 1, 2022 Sep 30, 2022
Q2 2022 -14.3 Apr 1, 2022 Jun 30, 2022
Q1 2022 -11.4 Jan 1, 2022 Mar 31, 2022

Janux Therapeutics, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -8.8 +7.15 +44.8% Jan 1, 2024 Dec 31, 2024
2023 -16 +0.93 +5.51% Jan 1, 2023 Dec 31, 2023
2022 -16.9 Jan 1, 2022 Dec 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.